• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液中的细胞角蛋白19片段(CYFRA 21-1):子宫内膜异位症的诊断标志物?

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?

作者信息

Gjavotchanoff Risto

机构信息

Department of Laboratory Medicine, Bodenseelabor, Hörbranz, Austria ; Institute of Anatomy II, University of Jena, Jena University Hospital, Jena, Germany.

出版信息

Int J Womens Health. 2015 Feb 9;7:205-11. doi: 10.2147/IJWH.S75288. eCollection 2015.

DOI:10.2147/IJWH.S75288
PMID:25709504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4332289/
Abstract

Diagnostic workup of endometriosis usually involves laparoscopic inspection and histological examination of biopsies. Unequivocal laboratory parameters for this ailment have not been available in routine diagnostic evaluations thus far. In this study, we examined urine concentrations of cytokeratin 19 (CYFRA 21-1), a structural protein specific for epithelia. We performed immunoassays for CYFRA 21-1 in urine samples from women afflicted with endometriosis throughout their menstrual cycle. We observed a significant increase in CYFRA 21-1 concentrations, corrected by creatinine levels, in the late follicular phase as compared with the level in healthy controls. We conclude that cyclically increased CYFRA 21-1 concentrations in urine could serve as a valuable noninvasive diagnostic parameter in the workup of clinically manifesting endometriosis.

摘要

子宫内膜异位症的诊断检查通常包括腹腔镜检查和活检组织学检查。迄今为止,在常规诊断评估中尚未有明确的该疾病实验室参数。在本研究中,我们检测了细胞角蛋白19(CYFRA 21-1)的尿液浓度,CYFRA 21-1是一种上皮特异性结构蛋白。我们对患有子宫内膜异位症的女性在整个月经周期的尿液样本进行了CYFRA 21-1免疫测定。我们观察到,与健康对照组相比,在卵泡晚期经肌酐水平校正后的CYFRA 21-1浓度显著升高。我们得出结论,尿液中CYFRA 21-1浓度的周期性升高可作为临床显性子宫内膜异位症诊断检查中有价值的非侵入性诊断参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/890bd4ad011e/ijwh-7-205Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/2b390eedbbe3/ijwh-7-205Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/ac48b1d5525c/ijwh-7-205Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/e4b953e0ab87/ijwh-7-205Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/890bd4ad011e/ijwh-7-205Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/2b390eedbbe3/ijwh-7-205Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/ac48b1d5525c/ijwh-7-205Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/e4b953e0ab87/ijwh-7-205Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a31/4332289/890bd4ad011e/ijwh-7-205Fig4.jpg

相似文献

1
CYFRA 21-1 in urine: a diagnostic marker for endometriosis?尿液中的细胞角蛋白19片段(CYFRA 21-1):子宫内膜异位症的诊断标志物?
Int J Womens Health. 2015 Feb 9;7:205-11. doi: 10.2147/IJWH.S75288. eCollection 2015.
2
Urine and serum concentrations of Cytokeratin 19 in preeclampsia.子痫前期患者尿液和血清中细胞角蛋白19的浓度
Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:311-5. doi: 10.1016/j.ejogrb.2014.08.020. Epub 2014 Aug 27.
3
New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer.用于测定细胞角蛋白19片段21-1的新型电化学发光免疫分析法:膀胱癌患者尿液样本的分析评估及临床诊断性能
Clin Chem. 1999 Nov;45(11):1944-53.
4
Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.评估尿CYFRA 21-1用于检测原发性和复发性膀胱癌的情况。
Cancer. 2002 Jun 1;94(11):2914-22. doi: 10.1002/cncr.10565.
5
CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis.细胞角蛋白 19 片段 21-1 和胎盘生长因子作为子宫内膜异位症的筛查标志物。
Med Sci Monit. 2019 Feb 9;25:1087-1092. doi: 10.12659/MSM.912787.
6
[The clinical usefulness of urinary determinations of cytokeratin 19 fragment (CYFRA 21-1) in urothelial tumor].
Hinyokika Kiyo. 1995 Aug;41(8):589-92.
7
Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer.可溶性细胞角蛋白19片段(CYFRA 21-1)在膀胱癌患者血清和尿液中的临床评估
Urology. 1996 Nov;48(5):703-10. doi: 10.1016/S0090-4295(96)00253-1.
8
Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions.细胞角蛋白片段19.1和19.21(细胞角蛋白19片段,Cyfra 21-1)在鉴别恶性和良性胸腔积液中的应用。
Aust N Z J Med. 1999 Dec;29(6):765-9. doi: 10.1111/j.1445-5994.1999.tb00777.x.
9
Increased serum levels of mBDNF in women with minimal and mild endometriosis have no predictive power for the disease.在患有极轻度和轻度子宫内膜异位症的女性中,血清 mBDNF 水平升高对该疾病没有预测能力。
Exp Biol Med (Maywood). 2018 Jan;243(1):50-56. doi: 10.1177/1535370217742600. Epub 2017 Nov 15.
10
Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.细胞角蛋白19片段CYFRA 21-1与癌胚抗原、鳞状细胞癌抗原及神经元特异性烯醇化酶在肺癌中的比较:一项国际多中心研究结果
Eur J Clin Chem Clin Biochem. 1994 Mar;32(3):189-99.

引用本文的文献

1
Strengthening of CYFRA 21-1 using urine creatinine correction as potential endometriosis biomarker .使用尿肌酐校正来强化CYFRA 21-1作为潜在子宫内膜异位症生物标志物的作用。
F1000Res. 2025 May 14;13:46. doi: 10.12688/f1000research.135167.2. eCollection 2024.
2
Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.使用多种肿瘤标志物对无症状人群进行癌症筛查。
PLoS One. 2016 Jun 29;11(6):e0158285. doi: 10.1371/journal.pone.0158285. eCollection 2016.
3
Urinary biomarkers for the non-invasive diagnosis of endometriosis.

本文引用的文献

1
Diagnostic accuracy of urinary cytokeratin 19 fragment for endometriosis.尿细胞角蛋白19片段对子宫内膜异位症的诊断准确性
Reprod Sci. 2015 May;22(5):551-5. doi: 10.1177/1933719114553064. Epub 2014 Oct 8.
2
Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis--a prospective study.细胞角蛋白 19 作为诊断子宫内膜异位症的尿液和血清生物标志物——一项前瞻性研究。
Gynecol Endocrinol. 2014 Jan;30(1):38-41. doi: 10.3109/09513590.2013.856409. Epub 2013 Nov 12.
3
Endometriosis and cancer: what do we know?子宫内膜异位症与癌症:我们了解些什么?
用于子宫内膜异位症非侵入性诊断的尿液生物标志物。
Cochrane Database Syst Rev. 2015 Dec 23;2015(12):CD012019. doi: 10.1002/14651858.CD012019.
Minerva Ginecol. 2013 Apr;65(2):167-79.
4
Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study.基于症状的子宫内膜异位症预测模型的开发作为一种临床筛查工具:多中心研究的结果。
Fertil Steril. 2012 Sep;98(3):692-701.e5. doi: 10.1016/j.fertnstert.2012.04.022. Epub 2012 May 30.
5
Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis.尿肽谱分析鉴定出一组用于诊断和分期子宫内膜异位症的潜在生物标志物。
Fertil Steril. 2011 Mar 15;95(4):1261-6.e1-6. doi: 10.1016/j.fertnstert.2010.11.066. Epub 2011 Jan 21.
6
Discovery of a novel biomarker in the urine in women with endometriosis.在子宫内膜异位症女性的尿液中发现一种新型生物标志物。
Fertil Steril. 2011 Jan;95(1):46-9. doi: 10.1016/j.fertnstert.2010.05.016. Epub 2010 Jun 18.
7
Practice bulletin no. 114: management of endometriosis.第114号实践公告:子宫内膜异位症的管理
Obstet Gynecol. 2010 Jul;116(1):223-236. doi: 10.1097/AOG.0b013e3181e8b073.
8
Impaired down-regulation of E-cadherin and beta-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis.在不孕的子宫内膜异位症患者的分泌中期子宫内膜中,子宫内膜上皮细胞中 E-钙黏蛋白和β-连环蛋白蛋白表达的下调受损。
J Clin Endocrinol Metab. 2010 Jul;95(7):3437-45. doi: 10.1210/jc.2009-2713. Epub 2010 Apr 21.
9
Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers.基于六种血浆生物标志物联合分析的子宫内膜异位症无创诊断。
Hum Reprod. 2010 Mar;25(3):654-64. doi: 10.1093/humrep/dep425. Epub 2009 Dec 9.
10
Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer.非小细胞肺癌肿瘤组织中细胞角蛋白19表达与血清CYFRA 21-1水平的比较。
Pol Arch Med Wewn. 2009 Jan-Feb;119(1-2):33-7.